Choice Architecture and Mailed Colorectal Cancer Screening Outreach in a Community Health Setting
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to National Comprehensive Cancer Network
Related studies linked through entity extraction aliases.
Supportive Care Mobile Application for Patients With NSCLC
- Status
- COMPLETED
- Phase
- NA
Improving the Approach to and Management of the Older Patient With Metastatic Gastric Cancer
- Status
- UNKNOWN
- Phase
- NA
REVITALIZE: A Telehealth Intervention for Women With Advanced Ovarian Cancer and PARP Inhibitor-Related Fatigue
- Status
- COMPLETED
- Phase
- NA
Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)
- Status
- RECRUITING
- Phase
- PHASE2
TAS-102, Irinotecan, and Bevacizumab for the Treatment of Pre-treated Metastatic or Unresectable Colorectal Cancer, the TABAsCO Study
- Status
- COMPLETED
- Phase
- PHASE2
Use of Trifluridine/Tipiracil and Oxaliplatin as Induction Chemotherapy for the Treatment of Resectable Esophageal or Gastroesophageal Junction (GEJ) Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Trifluridine/Tipiracil and Irinotecan for the Treatment of Advanced Refractory Biliary Tract Cancer
- Status
- COMPLETED
- Phase
- PHASE2
National Comprehensive Cancer Network (NCCN) Decision Support Tool for Patients With NSCLC
- Status
- COMPLETED
- Phase
- NA
Phase II Randomized Trial of Carboplatin+Pemetrexed+Bevacizumab+/- Atezolizumab in Stage IV NSCLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Afatinib and Nivolumab as Treatment for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
- Status
- WITHDRAWN
- Phase
- PHASE1
Osimertinib, Surgery, and Radiation Therapy in Treating Patients With Stage IIIB or IV Non-small Cell Lung Cancer With EGFR Mutations, NORTHSTAR Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Phase 2 Study of Osimertinib in Combination With Selumetinib in EGFR Inhibitor naïve Advanced EGFR Mutant Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Bavituximab With Radiation and Temozolomide for Patients With Newly Diagnosed Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2
Afatinib and Necitumumab in Patients With EGFR Mutation Positive Advanced or Metastatic Non-small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Mirvetuximab Soravtansine (IMG853) in Folate Receptor Alpha-expressing TNBC
- Status
- WITHDRAWN
- Phase
- PHASE1
Improving the Approach to and Management of the Older Metastatic Breast Cancer Patient
- Status
- COMPLETED
- Phase
- NA
Sorafenib and Bavituximab Plus SBRT in Unresectable Hepatocellular Carcinoma
- Status
- WITHDRAWN
- Phase
- PHASE1
Dual Inhibition of EGFR With Afatinib and Cetuximab in the Treatment of Advanced Squamous Cell Cancers of the Head and Neck
- Status
- COMPLETED
- Phase
- PHASE2
Four Conversations RCT
- Status
- COMPLETED
- Phase
- NA